Annual Accounts Receivable
$489.02 M
-$5.63 M-1.14%
31 December 2023
Summary:
Bio-Rad Laboratories annual accounts receivable is currently $489.02 million, with the most recent change of -$5.63 million (-1.14%) on 31 December 2023. During the last 3 years, it has risen by +$69.59 million (+16.59%). BIO annual accounts receivable is now -1.14% below its all-time high of $494.64 million, reached on 31 December 2022.BIO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$461.94 M
+$16.43 M+3.69%
30 September 2024
Summary:
Bio-Rad Laboratories quarterly accounts receivable is currently $461.94 million, with the most recent change of +$16.43 million (+3.69%) on 30 September 2024. Over the past year, it has increased by +$4.54 million (+0.99%). BIO quarterly accounts receivable is now -7.29% below its all-time high of $498.27 million, reached on 31 March 2023.BIO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIO Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.1% | +1.0% |
| 3 y3 years | +16.6% | +10.6% |
| 5 y5 years | +24.6% | +29.8% |
BIO Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1.1% | +16.6% | -7.3% | +10.6% |
| 5 y | 5 years | -1.1% | +24.6% | -7.3% | +29.8% |
| alltime | all time | -1.1% | +168.3% | -7.3% | +153.5% |
Bio-Rad Laboratories Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $461.94 M(+3.7%) |
| June 2024 | - | $445.51 M(+0.2%) |
| Mar 2024 | - | $444.81 M(-9.0%) |
| Dec 2023 | $489.02 M(-1.1%) | $489.02 M(+6.9%) |
| Sept 2023 | - | $457.40 M(-7.0%) |
| June 2023 | - | $491.57 M(-1.3%) |
| Mar 2023 | - | $498.27 M(+0.7%) |
| Dec 2022 | $494.64 M(+16.8%) | $494.64 M(+14.4%) |
| Sept 2022 | - | $432.30 M(-4.0%) |
| June 2022 | - | $450.32 M(-3.0%) |
| Mar 2022 | - | $464.11 M(+9.6%) |
| Dec 2021 | $423.54 M(+1.0%) | $423.54 M(+1.4%) |
| Sept 2021 | - | $417.71 M(+4.6%) |
| June 2021 | - | $399.31 M(-2.2%) |
| Mar 2021 | - | $408.14 M(-2.7%) |
| Dec 2020 | $419.42 M(+6.8%) | $419.42 M(+4.3%) |
| Sept 2020 | - | $402.24 M(+11.5%) |
| June 2020 | - | $360.85 M(-5.2%) |
| Mar 2020 | - | $380.48 M(-3.1%) |
| Dec 2019 | $392.67 M(+0.1%) | $392.67 M(+10.3%) |
| Sept 2019 | - | $356.02 M(-5.8%) |
| June 2019 | - | $377.90 M(-3.5%) |
| Mar 2019 | - | $391.70 M(-0.2%) |
| Dec 2018 | $392.44 M(-15.6%) | $392.44 M(+2.9%) |
| Sept 2018 | - | $381.53 M(-5.6%) |
| June 2018 | - | $404.09 M(-6.1%) |
| Mar 2018 | - | $430.36 M(-7.4%) |
| Dec 2017 | $464.85 M(+24.8%) | $464.85 M(+10.8%) |
| Sept 2017 | - | $419.71 M(+6.8%) |
| June 2017 | - | $392.84 M(+5.2%) |
| Mar 2017 | - | $373.44 M(+0.3%) |
| Dec 2016 | $372.35 M(-4.9%) | $372.35 M(+1.3%) |
| Sept 2016 | - | $367.66 M(+0.4%) |
| June 2016 | - | $366.28 M(-3.9%) |
| Mar 2016 | - | $381.10 M(-2.7%) |
| Dec 2015 | $391.49 M(+3.7%) | $391.49 M(+14.6%) |
| Sept 2015 | - | $341.55 M(-3.6%) |
| June 2015 | - | $354.16 M(+3.5%) |
| Mar 2015 | - | $342.22 M(-9.4%) |
| Dec 2014 | $377.64 M(-10.7%) | $377.64 M(+6.6%) |
| Sept 2014 | - | $354.40 M(-6.5%) |
| June 2014 | - | $378.89 M(-1.3%) |
| Mar 2014 | - | $383.93 M(-9.2%) |
| Dec 2013 | $422.66 M(+6.0%) | $422.66 M(+10.2%) |
| Sept 2013 | - | $383.47 M(-3.2%) |
| June 2013 | - | $395.97 M(+4.9%) |
| Mar 2013 | - | $377.55 M(-5.3%) |
| Dec 2012 | $398.74 M | $398.74 M(+6.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $375.80 M(+0.5%) |
| June 2012 | - | $373.82 M(-3.6%) |
| Mar 2012 | - | $387.62 M(-2.8%) |
| Dec 2011 | $398.67 M(+2.8%) | $398.67 M(+6.3%) |
| Sept 2011 | - | $375.03 M(-5.0%) |
| June 2011 | - | $394.91 M(+1.6%) |
| Mar 2011 | - | $388.55 M(+0.1%) |
| Dec 2010 | $388.00 M(+12.2%) | $388.00 M(+5.3%) |
| Sept 2010 | - | $368.60 M(+9.9%) |
| June 2010 | - | $335.35 M(-2.8%) |
| Mar 2010 | - | $344.99 M(-0.2%) |
| Dec 2009 | $345.73 M(+1.8%) | $345.73 M(-1.4%) |
| Sept 2009 | - | $350.76 M(+4.4%) |
| June 2009 | - | $335.83 M(+2.9%) |
| Mar 2009 | - | $326.31 M(-3.9%) |
| Dec 2008 | $339.65 M(-5.1%) | $339.65 M(-2.5%) |
| Sept 2008 | - | $348.25 M(-7.6%) |
| June 2008 | - | $376.99 M(+2.9%) |
| Mar 2008 | - | $366.51 M(+2.4%) |
| Dec 2007 | $358.08 M(+22.2%) | $358.08 M(+18.1%) |
| Sept 2007 | - | $303.20 M(-0.0%) |
| June 2007 | - | $303.27 M(+4.5%) |
| Mar 2007 | - | $290.12 M(-1.0%) |
| Dec 2006 | $292.97 M(+18.5%) | $292.97 M(+7.2%) |
| Sept 2006 | - | $273.37 M(+0.1%) |
| June 2006 | - | $273.01 M(+5.3%) |
| Mar 2006 | - | $259.23 M(+4.9%) |
| Dec 2005 | $247.19 M(-5.4%) | $247.19 M(+1.1%) |
| Sept 2005 | - | $244.47 M(+0.4%) |
| June 2005 | - | $243.39 M(-3.0%) |
| Mar 2005 | - | $250.97 M(-3.9%) |
| Dec 2004 | $261.24 M(+11.6%) | $261.24 M(+14.5%) |
| Sept 2004 | - | $228.19 M(-2.5%) |
| June 2004 | - | $234.00 M(+2.2%) |
| Mar 2004 | - | $228.93 M(-2.2%) |
| Dec 2003 | $234.09 M(+10.3%) | $234.09 M(+7.5%) |
| Sept 2003 | - | $217.67 M(+2.7%) |
| June 2003 | - | $211.92 M(-1.0%) |
| Mar 2003 | - | $213.96 M(+0.8%) |
| Dec 2002 | $212.28 M(+9.2%) | $212.28 M(+5.5%) |
| Sept 2002 | - | $201.26 M(+0.6%) |
| June 2002 | - | $199.97 M(+2.0%) |
| Mar 2002 | - | $196.00 M(+0.8%) |
| Dec 2001 | $194.40 M(+6.7%) | $194.40 M(+4.3%) |
| Sept 2001 | - | $186.39 M(-0.2%) |
| June 2001 | - | $186.71 M(-2.7%) |
| Mar 2001 | - | $191.79 M(+5.2%) |
| Dec 2000 | $182.24 M | $182.24 M |
FAQ
- What is Bio-Rad Laboratories annual accounts receivable?
- What is the all time high annual accounts receivable for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual accounts receivable year-on-year change?
- What is Bio-Rad Laboratories quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly accounts receivable year-on-year change?
What is Bio-Rad Laboratories annual accounts receivable?
The current annual accounts receivable of BIO is $489.02 M
What is the all time high annual accounts receivable for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual accounts receivable is $494.64 M
What is Bio-Rad Laboratories annual accounts receivable year-on-year change?
Over the past year, BIO annual accounts receivable has changed by -$5.63 M (-1.14%)
What is Bio-Rad Laboratories quarterly accounts receivable?
The current quarterly accounts receivable of BIO is $461.94 M
What is the all time high quarterly accounts receivable for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly accounts receivable is $498.27 M
What is Bio-Rad Laboratories quarterly accounts receivable year-on-year change?
Over the past year, BIO quarterly accounts receivable has changed by +$4.54 M (+0.99%)